Join ADLM
ADLM professional members save $125 on ADLM 2026. Join for just $275 a year and enjoy year-round benefits.
ADLM housing open to all – reserve now!
Next-Level Diagnostics with the EXENT® System: Built for the Lab. Designed for the Clinic. Focused on the Patient.
Wednesday, July 29
10:15 – 11:15 a.m.
Exhibit Hall Theater 1
Presented by Thermo Fisher Scientific
Overview
This session examines current MG assessment practices and challenges, with a practical focus on M-protein measurement in blood and its impact on analytical confidence and clinical decision-making. Attendees will discover how the EXENT® System applies mass spectrometry in a purpose-built, automated solution—streamlining workflows, improving specificity, and enabling the lab to deliver clearer answers for clinicians and patients alike.
Outcome
- Review laboratory practices of monoclonal gammopathy (MG) assessment including the current challenges and opportunities
- Learn about M-protein measurement in the blood and how this impacts laboratory and clinical decisions
- Understand how mass spectrometry impacts the future of MG assessment
Moderator
Seth O'Brien
General Manager, Thermo Fisher Scientific
Speaker
Professor Stephen Harding
VP & General Manager, Thermo Fisher Scientific